Zydus Lifesciences gets FDA final approval for Micafungin for Injection

Zydus Lifesciences gets FDA final approval for Micafungin for Injection

Zydus Lifesciences (formerly Cadila Healthcare) has secured final approval for Micafungin for Injection, 50 mg/vial and 100 mg/vial, single-dose vials from the US Food and Drug Administration (FDA). The product is the generic version of Mycamine, and has approval for the treatment of a range of fungal infections. Besides, Micafungin for Injection, 50 mg/vial and […]